Solaris Bio develops serum-free culture media and related solutions for cell manufacturing in regenerative medicine, utilizing proprietary AI technology to enhance the safety and efficacy of cell products while reducing costs. The startup addresses the need for chemically defined and animal origin-free media formulations that optimize cell growth and differentiation for various therapeutic applications.
Funding
Funding not disclosed
Founders
Product
Problem
Cell manufacturing for regenerative medicine requires specialized culture media that often contain animal-derived components, posing risks of contamination, batch-to-batch variability, and adverse immune reactions in patients. Traditional media formulations may also lack the necessary components to optimize cell growth, differentiation, and therapeutic efficacy.
Solution
Solaris Bio develops and manufactures serum-free, chemically defined culture media and related reagents for cell therapy manufacturing, addressing the limitations of conventional media. Their animal origin-free (AF) and chemically defined (CD) formulations enhance the safety and consistency of cell products while reducing manufacturing costs. Solaris Bio leverages proprietary AI technology to optimize media formulations for specific cell types and therapeutic applications, supporting the development of next-generation regenerative medicines. In addition to off-the-shelf media, Solaris Bio offers custom media development services to tailor formulations to specific customer needs, including optimizing for exosome production, improving cell viability, and reducing residual media components.
Target Audience
The primary customers are cell therapy manufacturers, regenerative medicine companies, and research institutions involved in cell-based therapies and drug discovery.
Features
- Animal origin-free (AF) and chemically defined (CD) media formulations to minimize contamination risks and ensure consistency
- AI-driven media design to optimize cell growth, differentiation, and therapeutic efficacy
- Optimized media for mesenchymal stem cells (MSCs)
- MSC separation reagents, including collagenase AF, for efficient cell isolation
- Serum-free cell detachment reagents for improved expansion culture performance
- MSC cryopreservation solutions to minimize cell damage during freezing
- Custom media development services for tailored formulations